Ranbaxy
Sun Pharma inaugurates first Egypt production facility
February 23, 2017Manufacturing and Production, Sales and Marketing Egypt, India, Ranbaxy, Sun Pharma
Ranbaxy, a subsidiary of India’s Sun Pharma, has opened its first production facility in Egypt in a bid to further …
Daiichi pulls out of India with closure of 170-strong R&D plant
January 11, 2017Manufacturing and Production, Research and Development Daiichi Sankyo, Ranbaxy, Sun Pharma
Japanese pharma firm Daiichi Sankyo has announced its intention to close its R&D centre in Gurgaon, India, a step in …
Sun Pharma sacks 18 Ranbaxy executives
June 19, 2015Manufacturing and Production, Sales and Marketing Daiichi, India, Ranbaxy, Sun Pharma, brett wells
Sun Pharma has asked 18 executives to leave the company who were previously a part of Ranbaxy, the firm it …
Daiichi Sankyo to sell Sun Pharma stake
April 21, 2015Manufacturing and Production, Sales and Marketing Daiichi Sankyo, FDA, India, Ranbaxy, Sun Pharma, generics
Daiichi Sankyo is to sell off all or part of its stake in Sun Pharma and back away from the …
Daiichi Sankyo cuts 16% of US staff
March 27, 2015Sales and Marketing Benicar, Daiichi Sankyo, FDA, Ranbaxy, Welchol, ambit, colesevelam, cuts, olmesartan
Daiichi Sankyo is laying off 16% of its staff at its US commercial headquarters as the company braces itself for …
Sun Pharma completes Ranbaxy acquisition
March 26, 2015Manufacturing and Production, Sales and Marketing Daiichi Sankyo, India, Ranbaxy, Sun Pharma, cci
Sun Pharma has closed its mega merger deal with Ranbaxy and begun the integration of the two businesses. The combined …
Sun Pharma and Ranbaxy merger gets US nod
February 2, 2015Manufacturing and Production, Sales and Marketing India, Ranbaxy, Sun Pharma, US, generics, merger, recall, torrent
The US Federal Trade Commission has given its approval for Sun Pharma’s $4 billion acquisition of troubled Indian firm Ranbaxy …
Gilead and Strides partner in HIV
January 21, 2015Research and Development, Sales and Marketing Cipla, FDA, Gilead, HIV, Ranbaxy, Tenofovir Alafenamide, WHO, strides, taf
Gilead is partnering with India-based pharma firm Strides Arcolab in a licensing agreement to manufacture and distribute an HIV treatment …
Ranbaxy and Sun Pharma merger approved
December 9, 2014Manufacturing and Production, Sales and Marketing FDA, Ranbaxy, Sun Pharma, cci, tamsulosin, tolterodine
The Competition Commission of India (CCI) has approved Sun Pharma’s acquisition of struggling drugmaker Ranbaxy, subject to conditions designed to …
AZ triumphs in Nexium pay-for-delay trial
December 8, 2014Sales and Marketing AstraZeneca, Dr Reddy's, Nexium, Ranbaxy, dr reddys, esomeprazole
AstraZeneca and Ranbaxy have avoided what might have been a $10 billion pay out regarding delays to the generic version …
Ranbaxy launches J&J biosimilar in India
December 5, 2014Manufacturing and Production, Sales and Marketing CHMP, FDA, India, J&J, JJ, Ranbaxy, Remicade, nlem, nppa
Ranbaxy has launched the first biosimilar of Johnson & Johnson’s Remicade (infliximab) in India, marking the firm’s entry into monoclonal …
Ranbaxy’s Diovan copycat approved in US
June 27, 2014Manufacturing and Production, Sales and Marketing Diovan, FDA, Novartis, Ranbaxy, blood pressure, sun pharmaceuticals, valsartan
Ranbaxy has won approval for its copycat form of Novartis’ blockbuster blood pressure drug Diovan, as the Swiss firm finally …
Ranbaxy woes hit profits
May 13, 2014Manufacturing and Production, Sales and Marketing Q1, Ranbaxy, Sun Pharma, manufacturing, recall
Indian generics maker Ranbaxy Laboratories has slipped up in the first quarter of the year, with profit sliding to 0.3 …
Court stops Ranbaxy takeover
May 6, 2014Manufacturing and Production, Sales and Marketing Ranbaxy, Sun Pharma, fad, manufacturing
An Indian court has stopped the sale of Ranbaxy Laboratories to Sun Pharmaceutical Industries after concerns were raised over insider …
Regulatory woes eclipse Sun Pharma deal
April 10, 2014Manufacturing and Production, Sales and Marketing FDA, India, Ranbaxy, Sun Pharma
The $4 billion merger between Indian generic firms Sun Pharma and Ranbaxy has been soured by reports that the deal …
